相似文献
1
The pathophysiology of negative symptoms of schizophrenia: main hypotheses and open challenges.
Br J Psychiatry. 2023 Jul;223(1):298-300. doi: 10.1192/bjp.2023.63.
2
Negative symptoms of schizophrenia: new developments and unanswered research questions.
Lancet Psychiatry. 2018 Aug;5(8):664-677. doi: 10.1016/S2215-0366(18)30050-6. Epub 2018 Mar 27.
3
[Hypofrontality and negative symptoms in schizophrenia: synthesis of anatomic and neuropsychological knowledge and ecological perspectives].
Encephale. 2001 Sep-Oct;27(5):405-15.
4
Modelling prefrontal cortex deficits in schizophrenia: implications for treatment.
Br J Pharmacol. 2008 Mar;153 Suppl 1(Suppl 1):S465-70. doi: 10.1038/bjp.2008.24.
5
Negative symptoms and hypofrontality in chronic schizophrenia.
Arch Gen Psychiatry. 1992 Dec;49(12):959-65. doi: 10.1001/archpsyc.1992.01820120047007.
6
[Scale for assessing negative symptoms in schizophrenia: A systematic review].
Encephale. 2016 Apr;42(2):165-71. doi: 10.1016/j.encep.2015.12.020. Epub 2016 Feb 26.
7
Categorizing and assessing negative symptoms.
Curr Opin Psychiatry. 2017 May;30(3):201-208. doi: 10.1097/YCO.0000000000000322.
8
[Current status of epigenetics of schizophrenia].
Nihon Rinsho. 2013 Apr;71(4):605-9.
9
Negative symptoms of schizophrenia: a problem that will not go away.
Acta Psychiatr Scand. 2007 Jan;115(1):4-11. doi: 10.1111/j.1600-0447.2006.00947.x.
10
Exploring Continuum and Categorical Conceptualisations of Mental Health and Mental Illness on Australian Websites: A Systematic Review and Content Analysis.
Community Ment Health J. 2023 Feb;59(2):275-289. doi: 10.1007/s10597-022-01005-w. Epub 2022 Aug 22.
引用本文的文献
1
Pharmacological Interventions for Negative Symptoms in Schizophrenia: A Systematic Review of Randomised Control Trials.
Biomedicines. 2025 Feb 21;13(3):540. doi: 10.3390/biomedicines13030540.
2
Multi-feature fusion RFE random forest for schizophrenia classification and treatment response prediction.
Sci Rep. 2025 Mar 12;15(1):8594. doi: 10.1038/s41598-025-89359-5.
3
Factors Affecting Negative Symptoms in Schizophrenia and Their Relationship with Anxiety and Depression.
Neuropsychiatr Dis Treat. 2025 Feb 4;21:229-240. doi: 10.2147/NDT.S492849. eCollection 2025.
4
Advancement in utilization of magnetic resonance imaging and biomarkers in the understanding of schizophrenia.
World J Clin Cases. 2025 Jan 6;13(1):96578. doi: 10.12998/wjcc.v13.i1.96578.
5
Pentoxifylline adjunct to risperidone for negative symptoms of stable schizophrenia: a randomized, double-blind, placebo-controlled trial.
Int J Neuropsychopharmacol. 2024 Dec 28;28(1). doi: 10.1093/ijnp/pyae051.
6
The efficacy and safety of dual-target rTMS over dorsolateral prefrontal cortex (DLPFC) and cerebellum in the treatment of negative symptoms in first-episode schizophrenia: Protocol for a multicenter, randomized, double-blind, sham-controlled study.
Schizophr Res Cogn. 2024 Nov 29;39:100339. doi: 10.1016/j.scog.2024.100339. eCollection 2025 Mar.
7
Pharmacological Treatments of Negative Symptoms in Schizophrenia-An Update.
J Clin Med. 2024 Sep 23;13(18):5637. doi: 10.3390/jcm13185637.
本文引用的文献
1
EPA guidance on assessment of negative symptoms in schizophrenia.
Eur Psychiatry. 2021 Feb 18;64(1):e23. doi: 10.1192/j.eurpsy.2021.11.
2
Prefrontal cortical thinning links to negative symptoms in schizophrenia via the ENIGMA consortium.
Psychol Med. 2018 Jan;48(1):82-94. doi: 10.1017/S0033291717001283. Epub 2017 May 26.
3
Ventral Striatal Activation During Reward Processing in Psychosis: A Neurofunctional Meta-Analysis.
JAMA Psychiatry. 2015 Dec;72(12):1243-51. doi: 10.1001/jamapsychiatry.2015.2196.
4
Neurobiological background of negative symptoms.
Eur Arch Psychiatry Clin Neurosci. 2015 Oct;265(7):543-58. doi: 10.1007/s00406-015-0590-4. Epub 2015 Mar 24.
5
The functional neuroanatomy of symptom dimensions in schizophrenia: a qualitative and quantitative review of a persistent question.
Neurosci Biobehav Rev. 2010 Mar;34(3):468-86. doi: 10.1016/j.neubiorev.2009.09.004. Epub 2009 Sep 20.
Zotero 插件